10th Annual UCHMC Research Symposium

Thursday, October 16, 2025, 8:00 AM - Friday, October 17, 2025, 5:00 AM, Irvine, CA, Irvine, CA


AMA PRA Category 1 Credits™ (6.50 hours), Non-Physician Attendance (6.50 hours)

The 10th Annual UCHMC Research Symposium will include discussions regarding opportunities for collaboration across the UC system, application of novel therapies in hematologic malignancies and ongoing clinical trials currently being conducted by the UC Hematologic Malignancies Consortium. The objectives of this meeting are to gain an understanding of how basic research discoveries are being translated into clinical trials, gain a better understanding of best practice in the management of hematologic malignancies, and to become familiar with targeted and immunotherapeutic approaches for the treatment of hematologic malignancies. Physicians, mid-level practitioners, clinical trials staff, fellows, students, basic and translational scientists are encouraged to attend and participate. We are hopeful that this meeting will help (1) patients receive effective treatments, (2) develop innovative clinical trials and (3) spur new translational laboratory investigations within the UC system.

1. Translate how new drug discoveries in the lab can be applied in clinical trials.
2. Design multi-center investigator initiated clinical trials based on presentations on UCHMC trials
3. Identify the role of clinical trials in daily practice
4. Discuss current developments in clinical care of patients with hematologic malignancies

ADA Statement: In compliance with the Americans with Disabilities Act, we will make every reasonable effort to accommodate your request.  For any special requests, please contact the activity administrator before the meeting date.

The University of California, Irvine School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

University of California, Irvine School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.